Multiomics Analysis of Homologous Recombination Deficiency Across Cancer Types
Author Information
Author(s): Dong Lin, Li Lin, Zhu Linyan, Xu Fei, Zhang Rumeng, Li Qiushuang, Zhu Yong, Zeng Zhutian, Ding Keshuo
Primary Institution: Anhui Medical University
Hypothesis
The study investigates the association of homologous recombination deficiency (HRD) with patient survival across various malignancies.
Conclusion
HRD is significantly associated with patient prognosis, but its impact varies among different cancer types.
Supporting Evidence
- HRD was found to be significantly associated with patient prognosis across 23 cancer types.
- High HRD levels correlated with lower overall survival rates in many cancers.
- Driver gene mutations were associated with HRD across specific cancer types.
Takeaway
This study looks at how a problem in DNA repair, called homologous recombination deficiency, affects cancer patients differently depending on their cancer type.
Methodology
The study conducted a multivariable omics analysis on HRD in 33 cancer types, focusing on patient prognosis, gene expression, gene mutation, and signaling pathways.
Limitations
The study primarily focuses on 23 cancers with significant associations, which may limit the generalizability of the findings.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website